CIK 0001698530 · Non-accelerated filer<br>Smaller reporting company
EXICURE, INC.
Sign in to watch- Ticker
- XCUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 815333008
- Phone
- 847-673-1707
- Business address
- 2430 N. HALSTED ST., CHICAGO, IL, 60614
- Former names
- Max-1 Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 9 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-06 | Venkatesan Jay Director | Option exercise · Stock Option (right to buy) | −9,310 | 0 | ||
| 2020-07-06 | Venkatesan Jay Director | Option exercise · Stock Option (right to buy) | −12,930 | 0 | ||
| 2020-06-12 | AURASENSE LLC 10% owner | Sale | −10,195 | $2.83 | $29K | 11,257,629 |
| 2020-06-12 | Mirkin Chad A. Director | Sale | −10,195 | $2.83 | $29K | 11,257,629 |
| 2020-06-04 | Muralidhar Bali Director | Grant or award · Stock Option (right to buy) | +21,693 | 21,693 | ||
| 2020-06-04 | WALT DAVID R Director | Grant or award · Stock Option (right to buy) | +21,693 | 21,693 | ||
| 2020-06-04 | Walbert Timothy P Director | Grant or award · Stock Option (right to buy) | +21,693 | 21,693 | ||
| 2020-06-04 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +21,693 | 21,693 | ||
| 2020-06-04 | Mirkin Chad A. Director | Grant or award · Stock Option (right to buy) | +21,693 | 21,693 | ||
| 2020-06-04 | Kim Helen Susan Director | Grant or award · Stock Option (right to buy) | +21,693 | 21,693 | ||
| 2020-06-04 | Hau Bosun Director | Grant or award · Stock Option (right to buy) | +21,693 | 21,693 | ||
| 2020-06-04 | Cleland Jeffrey L Director | Grant or award · Stock Option (right to buy) | +21,693 | 21,693 | ||
| 2020-06-03 | Feltner Douglas E. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2020-05-20 | Mirkin Chad A. Director | Option exercise | +49,649 | $0.65 | $32K | 64,649 |
| 2020-05-20 | Mirkin Chad A. Director | Option exercise · Stock Option (right to buy) | −49,649 | 0 | ||
| 2020-03-13 | Giljohann David A Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +871,504 | 871,504 | ||
| 2020-03-13 | WALT DAVID R Director | Purchase | +291,066 | $1.21 | $353K | 2,058,777 |
| 2020-03-13 | SNYDER DAVID S Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +230,200 | 230,200 | ||
| 2020-03-12 | SNYDER DAVID S Chief Financial Officer | Purchase | +18,248 | $1.40 | $26K | 18,248 |
| 2020-03-12 | Mirkin Chad A. Director | Purchase | +15,000 | $1.45 | $22K | 15,000 |
Page 4 of 7 · 122 trades